Personalized Medicine to Improve Treatment of Dopa-Responsive Dystonia—A Focus on Tyrosine Hydroxylase Deficiency
Dopa-responsive dystonia (DRD) is a rare movement disorder associated with defective dopamine synthesis. This impairment may be due to the fact of a deficiency in GTP cyclohydrolase I (GTPCHI, <i>GCH1</i> gene), sepiapterin reductase (SR), tyrosine hydroxylase (TH), or 6-pyruvoyl tetrahy...
Saved in:
Main Authors: | Gyrid Nygaard, Peter D. Szigetvari, Ann Kari Grindheim, Peter Ruoff, Aurora Martinez, Jan Haavik, Rune Kleppe, Marte I. Flydal |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/be20b1861c08418c9e12d4f3db470b2f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The dystonia patient a guide to practical management /
Published: (2009) -
PARK2 Patient Presenting with Dopa-Responsive Dystonia
by: Fumihito Yoshii, et al.
Published: (2021) -
Sexual dysfunction in cervical dystonia and blepharospasm
by: Marek M, et al.
Published: (2018) -
Association of Hepatitis C Virus Replication with the Catecholamine Biosynthetic Pathway
by: George Mpekoulis, et al.
Published: (2021) -
Tyrosine Hydroxylase Expression is Associated with Bone Marrow Infiltration in Neuroblastoma Patients
by: Samar El-Shazly, et al.
Published: (2021)